ArticleBMC medical genomics2024

SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.